Contributors

David Baker is professor of biochemistry and an HHMI investigator at the University of Washington. When he started there in 1994, the problem of "computing the structures of naturally occurring proteins and designing brand new ones [was] considered to be almost impossible," he says. His group has since created ROSETTA, a program that searches for lowest energy structures to do just this, and on page 34 he describes how it's being used to design an endonuclease to attack malaria

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

David Baker is professor of biochemistry and an HHMI investigator at the University of Washington. When he started there in 1994, the problem of "computing the structures of naturally occurring proteins and designing brand new ones [was] considered to be almost impossible," he says. His group has since created ROSETTA, a program that searches for lowest energy structures to do just this, and on page 34 he describes how it's being used to design an endonuclease to attack malaria and a potential vaccine for HIV.

Six years ago when Lee M. Silver, professor of molecular biology and public affairs at Princeton University, spent a nine-month sabbatical backpacking through Asia with his wife and three children, his eyes were opened to spiritual perspectives on issues such as genetically modified crops and stem cell research. In an excerpt from his new book Challenging Nature (p. 48), he argues that the concept of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies